Opportunity Information: Apply for HRSA 16 187

  • The HHS-HRSA in the health sector is offering a public funding opportunity titled "Ryan White HIV/AIDS Program Building Care and Prevention Capacity: Addressing the HIV Care Continuum in Southern Metropolitan Areas" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.145.
  • This funding opportunity was created on May 11, 2016 and posted on May 11, 2016.
  • Applicants must submit their applications by Jul 12, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
Apply for HRSA 16 187

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Ryan White HIV/AIDS Program Building Care and Prevention Capacity: Addressing the HIV Care Continuum in Southern Metropolitan Areas grant (HRSA-16-187) is a fiscal year 2016 discretionary cooperative agreement from HHS HRSA under CFDA 93.145. It is designed to fund one organization to operate as the Coordination and Technical Assistance Center (CTAC) for a new Secretary's Minority AIDS Initiative Fund (SMAIF) effort focused on strengthening HIV care and prevention outcomes in Southern metropolitan areas. The central aim is to support innovative service delivery models that measurably improve performance along the HIV care continuum in Ryan White HIV/AIDS Program (RWHAP) Part A jurisdictions, with a specific emphasis on reducing disparities affecting minority populations.

A key feature of the opportunity is that only a single award is expected, and the funded CTAC is responsible for both technical assistance and the distribution of service delivery funds through subawards. The CTAC must identify and support one subrecipient in each of four different RWHAP Part A jurisdictions located in the Southern United States. To ensure broader geographic reach, the program limits selection to no more than two subrecipients from Part A jurisdictions within the same state. The four subrecipients must be drawn from the 18 eligible RWHAP Part A jurisdictions within Florida, Georgia, Louisiana, North Carolina, Tennessee, Texas, and Virginia. Importantly, a subrecipient does not need to be an existing RWHAP provider, which opens the door for newer or non-traditional organizations that can effectively reach priority communities or implement strong linkage and retention strategies.

The project is built around expanding local capacity to serve minority populations across the HIV care continuum, with special focus on groups that often experience the largest gaps in diagnosis, engagement in care, and viral suppression. The populations explicitly highlighted include men who have sex with men (MSM), youth, cisgender women, transgender women, and people who inject drugs (PWID). The intended outcome is improved health results across continuum steps such as timely diagnosis, rapid linkage to care, sustained retention in care, antiretroviral therapy access and adherence, and ultimately viral suppression, while also addressing related prevention and co-infection needs when relevant.

The CTAC's responsibilities are extensive and hands-on. In collaboration with HRSA's HIV/AIDS Bureau (HAB), the CTAC must provide start-up and ongoing technical assistance to the four chosen subrecipients, delivered both onsite and virtually. This support is expected to cover a wide range of programmatic and operational activities that can improve local continuum performance and reduce racial, ethnic, and other disparities. Beyond advising, the CTAC also manages subawards that allow jurisdictions to expand or implement evidence-based or evidence-informed interventions. The CTAC is expected to provide continuing consultation on how subaward dollars are used, especially during early phases when new services, workflows, or partnerships are being launched.

A major program emphasis is finding people earlier and getting them into care faster, particularly individuals who are newly diagnosed as well as people who were previously diagnosed but are out of care. The CTAC is expected to help jurisdictions improve identification strategies, strengthen access points for entry into HIV medical care and prevention services, and tighten the handoff from screening and diagnosis to treatment. The announcement specifically recommends considering a "test and link" approach, where individuals move directly and almost immediately from receiving an HIV test result to concrete treatment and prevention interventions, whether in a community setting or a clinical environment. This underscores the program's focus on reducing delays, removing barriers, and improving navigation from the first point of contact through sustained care.

Coordination is also a formal requirement. The CTAC must work with HRSA HAB and coordinate with HRSA's Office of Regional Operations and the Centers for Disease Control and Prevention (CDC) on regional activities. This coordination is expected to happen through both virtual and in-person meetings and is intended to create shared learning opportunities, align efforts across agencies, and encourage collaborative problem-solving among participating jurisdictions and partners.

Another major deliverable is the CTAC's role in gathering, organizing, and sharing practical intervention knowledge. The CTAC is expected to collate and disseminate information on effective interventions from multiple recognized sources, including HRSA HAB Special Projects of National Significance (SPNS) dissemination efforts, the CDC Effective Interventions Compendium, International Association of Providers of AIDS Care (IAPAC) guidelines, peer-reviewed research, and lessons from the SMAIF-funded Care and Prevention in the United States (CAPUS) projects, many of which took place in Southern states. In other words, the CTAC is meant to function as both a technical support hub and an evidence translation engine, helping local implementers quickly identify what works, adapt it appropriately, and put it into practice.

The domains of activity that subawards and technical assistance may support are broad but clearly tied to continuum improvement. Examples highlighted in the announcement include increasing HIV testing and linkage to care; boosting testing and linkage for HIV and hepatitis C virus (HCV) co-infection; increasing HIV treatment coverage; strengthening retention in care and adherence to antiretroviral therapy (ART), alongside access to curative HCV treatment when appropriate; increasing viral suppression; and developing tailored approaches for the priority populations identified (MSM, youth, cisgender and transgender women, and PWID). The overall project period can run up to three years, giving the CTAC and its subrecipients time to launch interventions, refine implementation, and demonstrate measurable progress.

Eligibility is narrow in practice because the announcement expects a technically experienced organization to lead the work. Applicants are required to have at least a four-year history of developing and disseminating technical assistance to RWHAP recipients and subrecipient providers, and they are expected to collaborate with these partners in designing and carrying out the project. The application deadline listed in the opportunity is July 12, 2016, with the posting and creation date of May 11, 2016, reflecting that this was a time-limited competitive funding opportunity aimed at quickly scaling capacity-building support in Southern Part A metro areas where disparities have been persistent and the potential for impact is high.

Frequently Asked Questions (FAQs)

What is the official name of this grant opportunity?

The opportunity is titled: Ryan White HIV/AIDS Program Building Care and Prevention Capacity: Addressing the HIV Care Continuum in Southern Metropolitan Areas (HRSA-16-187).

Which federal agency is offering this funding?

This is a fiscal year 2016 discretionary cooperative agreement funded by the U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), specifically in coordination with HRSA's HIV/AIDS Bureau (HAB).

What CFDA number is associated with this opportunity?

The Catalog of Federal Domestic Assistance (CFDA) number listed is 93.145.

How many awards will be made under this announcement?

Only one award is expected. The funded organization will operate as the single Coordination and Technical Assistance Center (CTAC) for the project.

What is the CTAC?

The CTAC is the Coordination and Technical Assistance Center. Under this opportunity, one funded organization serves as the CTAC and is responsible for providing hands-on technical assistance and distributing service delivery funds through subawards to selected jurisdictions.

What is the central purpose of this funding?

The central aim is to support innovative service delivery models that measurably improve performance along the HIV care continuum in Ryan White HIV/AIDS Program (RWHAP) Part A jurisdictions in Southern metropolitan areas, with a specific focus on reducing disparities impacting minority populations.

What larger initiative is this CTAC supporting?

The CTAC supports a new Secretary's Minority AIDS Initiative Fund (SMAIF) effort focused on strengthening HIV care and prevention outcomes in Southern metropolitan areas.

What is meant by the "HIV care continuum" in this project?

Based on the announcement, the HIV care continuum focus includes improving outcomes such as timely diagnosis, rapid linkage to care, retention in care, access and adherence to antiretroviral therapy (ART), and achieving viral suppression, while addressing related prevention and co-infection needs when relevant.

Who are the priority populations emphasized in this grant?

The opportunity explicitly highlights populations that often experience the largest gaps across diagnosis, engagement in care, and viral suppression. These include: men who have sex with men (MSM), youth, cisgender women, transgender women, and people who inject drugs (PWID).

What are the main responsibilities of the funded CTAC?

The CTAC has extensive responsibilities, including:

  • Providing start-up and ongoing technical assistance to four selected subrecipients, delivered onsite and virtually.
  • Managing and distributing service delivery funds through subawards.
  • Providing continuing consultation on how subaward dollars are used, especially during early implementation phases.
  • Working collaboratively with HRSA HAB and coordinating with HRSA's Office of Regional Operations and the CDC on regional activities.
  • Collating and disseminating practical intervention knowledge from recognized sources (for example, SPNS dissemination efforts, the CDC Effective Interventions Compendium, IAPAC guidelines, peer-reviewed research, and lessons from CAPUS projects).

Does the CTAC only provide technical assistance, or does it also fund services?

It does both. The CTAC provides technical assistance and also distributes service delivery funds through subawards to support evidence-based or evidence-informed interventions in the selected jurisdictions.

How many subrecipients must the CTAC support?

The CTAC must identify and support one subrecipient in each of four different RWHAP Part A jurisdictions located in the Southern United States (four subrecipients total).

Are there geographic rules for selecting the four subrecipients?

Yes. To ensure broader geographic reach, the program limits selection to no more than two subrecipients from Part A jurisdictions within the same state.

Which states are included for eligible Part A jurisdictions?

The four subrecipients must be drawn from the 18 eligible RWHAP Part A jurisdictions within the following states: Florida, Georgia, Louisiana, North Carolina, Tennessee, Texas, and Virginia.

Do subrecipients have to be existing Ryan White HIV/AIDS Program providers?

No. The announcement states that a subrecipient does not need to be an existing RWHAP provider. This allows newer or non-traditional organizations to participate if they can effectively reach priority communities or implement strong linkage and retention strategies.

What types of activities can subawards and technical assistance support?

Examples in the announcement include activities tied to improving HIV care continuum outcomes, such as:

  • Increasing HIV testing and linkage to care
  • Boosting testing and linkage for HIV and hepatitis C virus (HCV) co-infection
  • Increasing HIV treatment coverage
  • Strengthening retention in care and ART adherence
  • Supporting access to curative HCV treatment when appropriate
  • Increasing viral suppression
  • Developing tailored approaches for MSM, youth, cisgender women, transgender women, and PWID

What is the "test and link" approach referenced in the announcement?

The announcement recommends considering a "test and link" approach, where individuals move directly and almost immediately from receiving an HIV test result to concrete treatment and prevention interventions, whether in a community setting or a clinical environment. The intent is to reduce delays, remove barriers, and strengthen navigation from first contact through sustained care.

What populations does the project especially aim to reach earlier?

A major emphasis is identifying people earlier and getting them into care faster, particularly individuals who are newly diagnosed and people who were previously diagnosed but are out of care.

How is coordination with other agencies handled?

Coordination is a formal requirement. The CTAC must work with HRSA HAB and coordinate with HRSA's Office of Regional Operations and the Centers for Disease Control and Prevention (CDC) on regional activities through both virtual and in-person meetings.

What sources of evidence and guidance is the CTAC expected to use and share?

The CTAC is expected to collate and disseminate intervention information from multiple recognized sources, including:

  • HRSA HAB Special Projects of National Significance (SPNS) dissemination efforts
  • The CDC Effective Interventions Compendium
  • International Association of Providers of AIDS Care (IAPAC) guidelines
  • Peer-reviewed research
  • Lessons from SMAIF-funded Care and Prevention in the United States (CAPUS) projects

What is the anticipated length of the project period?

The overall project period can run up to three years, allowing time to launch interventions, refine implementation, and demonstrate measurable progress.

What kind of organization is expected to apply to be the CTAC?

Eligibility is narrow in practice. Applicants are required to have at least a four-year history of developing and disseminating technical assistance to RWHAP recipients and subrecipient providers, and they are expected to collaborate with those partners in designing and carrying out the project.

Is this opportunity a grant or a cooperative agreement?

The announcement describes it as a discretionary cooperative agreement, which typically indicates substantial involvement and collaboration with the federal agency (HRSA/HAB) during implementation.

What is the application deadline listed in the opportunity?

The listed application deadline is July 12, 2016.

When was this opportunity posted/created?

The posting and creation date listed is May 11, 2016.

What is the overall focus on disparities in this program?

The project is specifically designed to reduce disparities affecting minority populations by expanding local capacity and improving continuum outcomes for groups that often face the greatest gaps in diagnosis, engagement in care, and viral suppression.

Browse more business programs for HIV and AIDS support

Browse more opportunities from the same agency: HHS-HRSA

Browse more opportunities from the same category: Health

Next opportunity: From Association to Function in the Alzheimers Disease Post Genomics Era (R21)

Previous opportunity: Regional Alliances and Multistakeholder Partnerships to Stimulate (RAMPS) Cybersecurity Education and Workforce Development

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for HRSA 16 187

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (HRSA 16 187) also looked into and applied for these:

Funding Opportunity
From Association to Function in the Alzheimers Disease Post Genomics Era (R21) Apply for RFA AG 17 011

Funding Number: RFA AG 17 011
Agency: HHS-NIH11
Category: Health
Funding Amount: $200,000
Centers of Research Translation (CORT) (P50) Apply for RFA AR 17 001

Funding Number: RFA AR 17 001
Agency: HHS-NIH11
Category: Health
Funding Amount: $1,000,000
Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Tuberculosis Vaccine Design (R01) Apply for PAR 16 254

Funding Number: PAR 16 254
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent
Mississippi Delta Health Collaborative Apply for CDC RFA DP16 1612

Funding Number: CDC RFA DP16 1612
Agency: HHS-CDC-NCCDPHP
Category: Health
Funding Amount: $3,150,000
Public Health Preparedness and Response (PHPR) Cooperative Agreement for All-Hazards Public Health Emergencies: Zika 2016 Apply for CDC RFA TP16 1602

Funding Number: CDC RFA TP16 1602
Agency: HHS-CDC-OPHPR
Category: Health
Funding Amount: $5,000,000
Grants for Early Medical/Surgical Subspecialists' Transition to Aging Research (GEMSSTAR) (R03) Apply for RFA AG 17 012

Funding Number: RFA AG 17 012
Agency: HHS-NIH11
Category: Health
Funding Amount: $75,000
From Association to Function in the Alzheimers Disease Post Genomics Era (R01) Apply for RFA AG 17 010

Funding Number: RFA AG 17 010
Agency: HHS-NIH11
Category: Health
Funding Amount: $350,000
Establishment of Centers of Excellence in Refugee Health Apply for CDC RFA CK15 150302CONT16

Funding Number: CDC RFA CK15 150302CONT16
Agency: HHS-CDC-NCEZID
Category: Health
Funding Amount: Case Dependent
Learning Collaboratives for Advanced Business Acumen Skills Apply for HHS 2016 ACL CIP PPBA 0181

Funding Number: HHS 2016 ACL CIP PPBA 0181
Agency: HHS-ACL
Category: Health
Funding Amount: $500,000
Creutzfeldt - Jakob Disease (CJD) Support, Education, and Awareness Projects as Apply for CDC RFA CK15 150402CONT16

Funding Number: CDC RFA CK15 150402CONT16
Agency: HHS-CDC-NCEZID
Category: Health
Funding Amount: Case Dependent
Environmental Sampling with NAU for High Consequence Pathogens Apply for CDC RFA CK16 1606

Funding Number: CDC RFA CK16 1606
Agency: HHS-CDC-NCEZID
Category: Health
Funding Amount: $300,000
Children’s Hospitals Graduate Medical Education (CHGME) Payment Program Apply for HRSA 17 006

Funding Number: HRSA 17 006
Agency: HHS-HRSA
Category: Health
Funding Amount: Case Dependent
Jurisdictional Approach to Curing Hepatitis C Among HIV/HCV Coinfected People of Color - Evaluation and Technical Assistance Center Apply for HRSA 16 188

Funding Number: HRSA 16 188
Agency: HHS-HRSA
Category: Health
Funding Amount: Case Dependent
Inclusion of Mobile/e-Consents for Alzheimer's Disease Research (Admin Supp) Apply for PA 16 259

Funding Number: PA 16 259
Agency: HHS-NIH11
Category: Health
Funding Amount: $100,000
Jurisdictional Approach to Curing Hepatitis C among HIV/HCV Coinfected People of Color – Jurisdictional Sites Apply for HRSA 16 189

Funding Number: HRSA 16 189
Agency: HHS-HRSA
Category: Health
Funding Amount: Case Dependent
Reducing the Duration of Untreated Psychosis in the United States (R01) Apply for PAR 16 265

Funding Number: PAR 16 265
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent
Reducing the Duration of Untreated Psychosis in the United States (R34) Apply for PAR 16 264

Funding Number: PAR 16 264
Agency: HHS-NIH11
Category: Health
Funding Amount: $225,000
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01) Apply for PAR 16 262

Funding Number: PAR 16 262
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent
Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities Outside the United States Apply for CDC RFA IP16 1603

Funding Number: CDC RFA IP16 1603
Agency: HHS-CDC-NCIRD
Category: Health
Funding Amount: $400,000
NHLBI Career Transition Award for Intramural Fellows (K22) Apply for PAR 16 267

Funding Number: PAR 16 267
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 16 187", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.